Keywords: Novo Nordisl, Victoza, UK, NICE, Type 2 diabetes

UK’s NICE backs Novo Nordisk’s new type 2 diabetes drug Victoza for NHS use

Article | 10 September 2010

Print This

The UK’s National Institute for Health and Clinical Excellence (NICE), issued its Final Appraisal Determination (FAD) today, supporting ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in